Skip to main content

Nolato

Nolato AB is a Swedish polymer technology company engaged in the development and high-volume manufacturing of specialized polymer components and systems. The company operates through three primary business areas: Medical Solutions, developing plastic components and drug delivery devices for pharma and diagnostics; Engineered Solutions, producing polymer components for industrial and automotive applications; and Industrial Solutions. Its product suite encompasses insulin pens, asthma inhalers, diagnostic consumables, automotive shielding, and precision industrial molded parts. Principal revenue is generated from contract manufacturing sales of polymer components, specialized toolmaking fees, and precision assembly services for enterprise clients globally. Nolato holds a strong international market position as a specialized polymer developer and supplier to biopharmaceutical, medical technology, and industrial corporations. Headquartered in Torekov, Sweden, the company's Class B common stock is publicly listed and traded on Nasdaq Stockholm under the ticker NOLA B.

19 of the funds FundTelligence covers report a position in Nolato.

Legal name
Nolato AB
Sector
Industrials
Country
Sweden
Funds holding it
19

Funds holding Nolato

Showing the 8 largest of 19 funds holding it.

Loading...